Society for Cardiovascular Angiography Interventions (SCAI)

The Society for Cardiovascular Angiography and Interventions (SCAI) represents interventional cardiology through education, advocacy, research, setting guidelines and quality patient care. SCAI provides thought leadership in cath lab procedures, new technology and policy.

SCAI president reviews achievements in interventional cardiology in 2024
SCAI President James Hermiller, MD, recently outlined the key achievements for 2024, including creation of the first interventional cardiology match program, successful advocacy and efforts to increase women in the field.
Industry concerns over paclitaxel-coated devices may have put PAD patients at risk
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a significant impact on patient care.
Contrast injections during angiography, PCI unlikely to cause coronary injuries
The pressure changes associated with contrast injections are minimal, researchers noted, especially once you move away from the tip of the catheter.
Charles E. Mullins remembered as a pioneer of interventional pediatric cardiology
Charles E. Mullins, MD, a U.S. Army veteran who went on to practice medicine for five decades, died at the age of 92. SCAI shared a loving tribute to Mullins, calling him the "father of modern interventional pediatric cardiology."
Cardiologists reflect on developing primary PCI in face of criticism and pushback
SCAI celebrated cardiologists William W. O'Neill, MD, and Cindy L. Grines, MD, for the important roles they played in the development of primary PCI. “It was challenging,” Grines explained. “We had the pharmaceutical industry that was anti-primary angioplasty and we had a lot of our own colleagues that were anti-primary angioplasty."

Cardiologists join the FDA’s fight against menthol cigarettes, flavored cigars

The American College of Cardiology (ACC), Association of Black Cardiologists, American Heart Association and Society for Cardiovascular Angiography & Interventions are just some of the healthcare organizations supporting the FDA's proposal.

May 13, 2022

Several ACC 2022 late-breaking trials may have impacts on clinical practice for interventional cardiology and structural heart. One trial compared FFR vs. IVUS guided PCI for intermediate coronary lesions. Photos by Dave Fornell

Key interventional cardiology takeaways from ACC.22

Several late-breaking clinical trials at ACC.22 will likely impact clinical practice. Below are summaries of a few key trials and their takeaways for interventional cardiology and structural heart interventions.

April 11, 2022

What clinicians need to know about PCI, other revascularization techniques among women

The Society for Cardiovascular Angiography & Interventions has shared a new expert consensus statement that highlights sex-specific considerations associated with revascularization.

February 4, 2022

CMS finalizes 2022 Medicare Physician Fee Schedule—payments to cardiologists take a hit

Also, penalties for failing to comply with the Appropriate Use Criteria program have been delayed yet again.

November 3, 2021

Cardiologists urge CMS to reconsider MPFS changes that could ‘jeopardize the delivery of care’

The American College of Cardiology and Society for Cardiovascular Angiography (SCAI) and Interventions are just two of the medical societies concerned about this proposal.

September 10, 2021

Interventional cardiologists back prior authorization bill, call current policies ‘costly' and ‘time consuming’

The Society for Cardiovascular Angiography and Interventions is the latest industry organization to show its support of the new legislation.

May 28, 2021

SCAI 2021: Medtronic pleased with 30-day data on Evolut TAVR systems

Researchers presented 30-day data at the SCAI 2021 Scientific Sessions, highlighting the "excellent" outcomes and the importance of constantly working to improve patient care.

May 3, 2021

SCAI 2021: Harmony TPV could ‘fundamentally alter’ care for patients with congenital heart disease

Overall, one-year findings showed that there were no instances of mortality, endocarditis, major stent fractures or surgical intervention among patients who received the Harmony TPV.

April 30, 2021

Society for Cardiovascular Angiography Interventions (SCAI)

SCAI president reviews achievements in interventional cardiology in 2024

Industry concerns over paclitaxel-coated devices may have put PAD patients at risk

Contrast injections during angiography, PCI unlikely to cause coronary injuries

Charles E. Mullins remembered as a pioneer of interventional pediatric cardiology

Cardiologists reflect on developing primary PCI in face of criticism and pushback